Introduction: What Is Indacaterol Acetate?
Indacaterol acetate is a pharmaceutical active ingredient
associated with respiratory medicines used in the management of certain airway
conditions. It is the acetate salt of indacaterol, a long-acting beta-2
adrenergic agonist (LABA) that relaxes the muscles around the airways. Its
pharmaceutical relevance makes it a product of interest to chemical manufacturers,
formulation developers, procurement teams, and B2B buyers sourcing respiratory
medicine ingredients.
Kavya Pharma lists Indacaterol Acetate (Micronized) in its
pharmaceutical product catalogue. Buyers can review the company’s pharmaceutical
products and bulk drugs or enquire about product availability and technical
details directly.
What Is Indacaterol Acetate Used For?
Indacaterol acetate is used in the development and
manufacture of inhaled medicines for respiratory conditions. Indacaterol works
by stimulating beta-2 receptors in airway smooth muscle, helping muscles relax
and supporting bronchodilation. The specific approved use depends on the medicine's
formulation, active ingredients combination, and applicable regulatory
authorisation.
Certain inhalation products, such as indacaterol acetate may
be combined with other active ingredients as part of a prescribed maintenance
treatment. It is pertinent to distinguish the pharmaceutical ingredient from
the finished medicine: the ingredient itself is not a substitute for an
approved inhaler or medical advice.
For pharmaceutical businesses, the main points to understand
are:
- It
is associated with long-acting bronchodilator formulations.
- It
may be used in combination with products, depending on approved medicines.
- The
final dosage form and intended indication depend on the specific product
authorisation.
- Ingredient
identity, quality, and suitability must be established before formulation
or manufacture or use.
What Are the Key Identification Details of Indacaterol
Acetate?
Pharmaceutical ingredient sourcing begins with chemical
identification. Indacaterol acetate is listed in PubChem under CAS No. 1000160-96-2,
with the molecular formula C₂₆H₃₂N₂O₅ and a molecular weight of
approximately 452.5 g/mol. Buyers should confirm these details against
the exact material being quoted and its accompanying technical documentation.
A basic identification checklist includes:
- Product
name: Indocaterol Acetate
- CAS
number: 1000160-96-2
- Molecular
formula: C₂₆H₃₂N₂O₅
- Molecular
weight: Approximately 452.5 g/mol
- Product
form: Confirm whether the material is micronized or supplied in
another specified form
These details are useful for purchase enquiries, technical
reviews, inventory records, and supplier comparisons. However, identity
information alone does not establish that a material meets the requirements of
a particular pharmaceutical formulation. Buyers should request all applicable
specifications and batch documentation before approving a supplier.
Why Does Micronized Indacaterol Acetate Matter?
Micronization is a particle-size reduction process that
influences the physical properties of pharmaceutical ingredients. For
inhalation products, particle characteristics are particularly important. This
is because formulation performance may depend on factors such as particle-size
distribution, dispersion behaviour, and the delivery system design.
The word “micronized” should therefore be supported by
defined technical parameters rather than treated as a complete specification on
its own.
When evaluating micronized Indacaterol Acetate, buyers may
need to review:
- Particle-size
distribution and analytical method.
- Assays,
related substances, and all applicable impure limits.
- Moisture
content and other relevant physical properties.
- Batch-to-batch
consistency and traceability.
- Packaging,
handling, and storage instructions.
- The
formulation and manufacturing process must be compatible.
Not every specification applies to every product or process.
The buyer’s technical team should establish the required limits with reference
to the relevant product dossier, quality standards, and regulatory
expectations.
How Should Pharmaceutical Manufacturers Evaluate
Suppliers?
Selecting a supplier for Indacaterol acetate requires a
structured review of technical, quality, commercial, and supply-chain
considerations. A product listing is an ideal starting point, but it does not
replace supplier qualification.
Before procurement, pharmaceutical businesses should:
- Verify
the chemical identity and grade required.
- Request
a current Certificate of Analysis (COA) and relevant safety documentation.
- Review
available impure data and analytical methods.
- Clarify
whether the material is micronized and obtain its agreed particle-size
specification.
- Check
manufacturing or sourcing information and applicable quality
documentation.
- Discuss
available quantities, lead times, packaging, and transport conditions.
- Establish
procedures for handling deviations, complaints, and document updates.
For regulated pharmaceutical applications, additional
audits, quality agreements, regulatory documentation, or qualification
procedures may be required. Buyers should determine these requirements before
placing a commercial order.
What Should B2B Buyers Know About Pharmaceutical
Ingredient Sourcing in India?
India is a key market for pharmaceutical manufacturing,
formulation development, and ingredient sourcing. For both domestic and
international buyers, working with Indian suppliers can provide access to a
broad pharmaceutical supply network. Availability and suitability vary by
compound, grade, quantity, and supplier capabilities.
A practical sourcing enquiry should include:
- Exact
product name and CAS number.
- Requires
grade and technical specifications.
- Whether
a micronized material is needed.
- Estimated
order quantity and purchasing frequency.
- Destination
country and delivery timeline.
- Documentation
and regulatory requirements.
Clear information helps suppliers assess the inquiry more
efficiently and reduces the risk of receiving a quotation for a different salt,
grade, or material form. Buyers should also distinguish Indacaterol Acetate
from other indacaterol salts, such as indacaterol maleate. This is because
related names do not mean products are interchangeable.
Where Can Buyers Enquire About Indacaterol Acetate?
Kavya Pharma, based in Surat, Gujarat, India, lists
pharmaceutical ingredients and bulk drugs in its online catalogue. Businesses
researching Indacaterol Acetate can visit the Kavya Pharma pharmaceutical product catalogue to review the
available categories.
For related sourcing requirements, buyers can also explore
the company’s pharmaceutical intermediates and API
and bulk drug products.
Before making a purchase decision, request confirmation of
current availability, specifications, product grade, documentation, and
applicable supply conditions. These details should be reviewed by the buyer’s
procurement and quality team before the material is accepted for pharmaceutical
use.
Conclusion: Source Indacaterol Acetate from Kavya Pharma
Indocaterol acetate is a pharmaceutical ingredient
associated with long-acting bronchodilators. For pharmaceutical manufacturers
and B2B procurement teams, responsible sourcing begins with confirming chemical
identity. It also involves evaluating the required grade, reviewing technical
documentation, and checking supplier suitability for the intended application.
Kavya Pharma provides an online catalogue of pharmaceutical
products, intermediates, and bulk drugs for businesses exploring ingredient
sourcing options. Companies interested in Indacaterol Acetate can visit www.kavyapharma.com or
use the contact
page to enquire about product availability and specifications.
When contacting Kavya Pharma, include the CAS number,
required material form, quantity, destination, and documentation requirements.
This will help the team assess your B2B enquiry.

Comments
Post a Comment